Depressive symptoms in neurodegenerative diseases
- PMID: 26301229
- PMCID: PMC4539408
- DOI: 10.12998/wjcc.v3.i8.682
Depressive symptoms in neurodegenerative diseases
Abstract
Depressive symptoms are very common in chronic conditions. This is true so for neurodegenerative diseases. A number of patients with cognitive decline and dementia due to Alzheimer's disease and related conditions like Parkinson's disease, Lewy body disease, vascular dementia, frontotemporal degeneration amongst other entities, experience depressive symptoms in greater or lesser grade at some point during the course of the illness. Depressive symptoms have a particular significance in neurological disorders, specially in neurodegenerative diseases, because brain, mind, behavior and mood relationship. A number of patients may develop depressive symptoms in early stages of the neurologic disease, occurring without clear presence of cognitive decline with only mild cognitive deterioration. Classically, depression constitutes a reliable diagnostic challenge in this setting. However, actually we can recognize and evaluate depressive, cognitive or motor symptoms of neurodegenerative disease in order to establish their clinical significance and to plan some therapeutic strategies. Depressive symptoms can appear also lately, when the neurodegenerative disease is fully developed. The presence of depression and other neuropsychiatric symptoms have a negative impact on the quality-of-life of patients and caregivers. Besides, patients with depressive symptoms also tend to further decrease function and reduce cognitive abilities and also uses to present more affected clinical status, compared with patients without depression. Depressive symptoms are treatable. Early detection of depressive symptoms is very important in patients with neurodegenerative disorders, in order to initiate the most adequate treatment. We review in this paper the main neurodegenerative diseases, focusing in depressive symptoms of each other entities and current recommendations of management and treatment.
Keywords: Alzheimer; Dementia; Depression; Depressive symptoms; Frontotemporal degeneration; Lewy body disease; Neurodegenerative diseases; Vascular dementia.
Similar articles
-
Depressive Cognitive Disorders.2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32644682 Free Books & Documents.
-
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus.Eur J Neurol. 2018 Oct;25(10):1201-1217. doi: 10.1111/ene.13728. Epub 2018 Jul 20. Eur J Neurol. 2018. PMID: 29932266
-
Driving Difficulties Among Patients with Alzheimer's Disease and Other Neurodegenerative Disorders.J Alzheimers Dis. 2019;69(4):1019-1030. doi: 10.3233/JAD-181095. J Alzheimers Dis. 2019. PMID: 31045516
-
Late-life depression: a neuropsychiatric approach.Expert Rev Neurother. 2006 Jan;6(1):65-72. doi: 10.1586/14737175.6.1.65. Expert Rev Neurother. 2006. PMID: 16466313 Review.
-
Depression and Parkinson's disease: a Chicken-Egg story.AIMS Neurosci. 2022 Nov 23;9(4):479-490. doi: 10.3934/Neuroscience.2022027. eCollection 2022. AIMS Neurosci. 2022. PMID: 36660077 Free PMC article. Review.
Cited by
-
Major Depression and Onset of Frontotemporal Dementia.Neuropsychiatr Dis Treat. 2022 Nov 29;18:2807-2812. doi: 10.2147/NDT.S390385. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36471745 Free PMC article.
-
Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.CNS Drugs. 2016 Oct;30(10):889-97. doi: 10.1007/s40263-016-0369-9. CNS Drugs. 2016. PMID: 27395402 Review.
-
The Impact of Chronic Mild Stress and Agomelatine Treatment on the Expression Level and Methylation Status of Genes Involved in Tryptophan Catabolic Pathway in PBMCs and Brain Structures.Genes (Basel). 2020 Sep 18;11(9):1093. doi: 10.3390/genes11091093. Genes (Basel). 2020. PMID: 32962062 Free PMC article.
-
Factors associated with depression in patients with Parkinson's disease A multicenter study in Lima, Peru.Dement Neuropsychol. 2018 Jul-Sep;12(3):292-298. doi: 10.1590/1980-57642018dn12-030010. Dement Neuropsychol. 2018. PMID: 30425793 Free PMC article.
-
Mechanisms of protein toxicity in neurodegenerative diseases.Cell Mol Life Sci. 2018 Sep;75(17):3159-3180. doi: 10.1007/s00018-018-2854-4. Epub 2018 Jun 12. Cell Mol Life Sci. 2018. PMID: 29947927 Free PMC article. Review.
References
-
- Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 1988;145:976–981. - PubMed
-
- Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1996;8 Suppl 3:497–500. - PubMed
-
- Tay L, Lim WS, Chan M, Ali N, Mahanum S, Chew P, Lim J, Chong MS. New DSM-V Neurocognitive Disorders Criteria and Their Impact on Diagnostic Classifications of Mild Cognitive Impairment and Dementia in a Memory Clinic Setting. Am J Geriatr Psychiatry. 2015;23:768–779. - PubMed
-
- Prado-Jean A, Couratier P, Druet-Cabanac M, Nubukpo P, Bernard-Bourzeix L, Thomas P, Dechamps N, Videaud H, Dantoine T, Clément JP. Specific psychological and behavioral symptoms of depression in patients with dementia. Int J Geriatr Psychiatry. 2010;25:1065–1072. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources